These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy for locally advanced prostate cancer. Einstein AB NCI Monogr; 1988; (7):171-4. PubMed ID: 3050536 [TBL] [Abstract][Full Text] [Related]
8. Current treatment of advanced prostate cancer. Ismail M; Gomella LG Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220 [TBL] [Abstract][Full Text] [Related]
9. Combined androgen blockade: the gold standard for metastatic prostate cancer. McLeod DG; Crawford ED; DeAntoni EP Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789 [TBL] [Abstract][Full Text] [Related]
10. Innovative approaches to the hormonal treatment of advanced prostate cancer. Trachtenberg J Eur Urol; 1997; 32 Suppl 3():78-80. PubMed ID: 9267790 [TBL] [Abstract][Full Text] [Related]
11. Endocrine therapy for prostate cancer. Damber JE Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920 [TBL] [Abstract][Full Text] [Related]
12. Endocrine therapy for prostate cancer. Labrie F Endocrinol Metab Clin North Am; 1991 Dec; 20(4):845-72. PubMed ID: 1778180 [TBL] [Abstract][Full Text] [Related]
13. [The hormonal and chemotherapy of prostatic cancer]. Miron L Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):37-43. PubMed ID: 9455433 [TBL] [Abstract][Full Text] [Related]
15. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer. Scherr DS; Pitts WR J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759 [TBL] [Abstract][Full Text] [Related]
16. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T; J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218 [TBL] [Abstract][Full Text] [Related]
17. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
18. Hormonal ablation therapy for metastatic prostatic carcinoma: a review. Leewansangtong S; Soontrapa S J Med Assoc Thai; 1999 Feb; 82(2):192-205. PubMed ID: 10087729 [TBL] [Abstract][Full Text] [Related]
19. Overview of current status of total androgen deprivation in metastasized prostate cancer. Debruyne FM; Witjes WP Eur Urol; 1993; 24 Suppl 2():67-71. PubMed ID: 8262129 [TBL] [Abstract][Full Text] [Related]
20. Compliance with hormonal treatment for prostate cancer. Kaisary AV Br J Hosp Med; 1996 Mar 20-Apr 2; 55(6):359-66. PubMed ID: 8696636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]